Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Safety monitoring and information (101)
- Advertising (278)
- COVID-19 (163)
- Legislation (95)
- Compliance and enforcement (70)
- Manufacturing (55)
- Vaping hub (55)
- Labelling and packaging (37)
- Import and export (28)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Weight loss products (15)
- Shortages and supply disruptions (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
101 result(s) found, displaying 76 to 100
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
News articlesThe COVID-19 pandemic post-market review of facemasks is now finished.
-
Media releasesThe TGA has issued 7 infringement notices totalling $115,500 to the company for the alleged unlawful advertising and supply of sport supplement products containing banned substances.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Safety updatesA warning about anticoagulant-related nephropathy (ARN) has been added to the Product Information (PI) for all oral anticoagulants.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Safety updatesHealth professionals should check if patients undergoing general anaesthesia have used products containing pholcodine in the previous 12 months.
-
Media releasesFollowing a safety investigation into pholcodine the TGA are cancelling 55 products (from the ARTG) and recalling them from pharmacy shelves due to an increased risk of anaphylactic reactions.
-
News articlesBefore you take a weight loss supplement or medicine, there are things to consider.
-
BlogMake small changes to how you think about paracetamol.
-
News articlesThe Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.
-
Media releasesConsumers are advised to be cautious about ivermectin products that are sold by unverified online stores.
-
BlogEven if you're familiar with your pet's medicine, the advice is clear: if a product is labelled 'for animal use only', do not take it.
-
-
News articlesInterim statement concerning the use of GS1 Australia's Recall Health platform
-
BlogCounterfeit medicines pose a health risk, but our tips can help you spot them.
-
BlogBe informed and aware, but don’t be afraid.
-
Media releasesA warning to consumers about undergoing procedures using unapproved medical devices
-
BlogTim's story explains the risks of buying SARMs online.
-
Safety updatesIn this issue: Action after registry data analysis; Environmental extremes; Button battery dangers; Infant sleep positioners reviewed
-
Media releasesPharmacy software vendor links to TGA adverse event reporting web service